3.145.172.206
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Home Dr. Christine Kay highlights the TEASE study for Stargardt disease

Conference Roundup

Dr. Christine Kay highlights the TEASE study for Stargardt disease

Watch Now
By rd360stg
Modeling study observes extended durability of aflibercept 8 mg
By rd360stg
Matching study assesses faricimab versus aflibercept in DME and AMD
By rd360stg
TRUCKEE study assesses real-world efficacy and safety of faricimab in neovascular AMD
By rd360stg
Dr. Micheletti talks about the state of interventional glaucoma
-Advertisement-
-Advertisement-
-Advertisement-
By rd360stg
DAVIO 2: Dr. Regillo outlines the findings of EYP-1901 versus aflibercept in wet AMD
By rd360stg
Early-onset cataracts in pediatric patients: indicators, surgical intervention, and challenges
By rd360stg
Dr. Radcliffe shares highlights from a session covering the business of glaucoma
By rd360stg
Cost-effectiveness analysis of treatment options for geographic atrophy
-Advertisement-
-Advertisement-
-Advertisement-
By rd360stg
Regenxbio reports promising data on gene therapy for bilateral wet AMD
By rd360stg
Drs. Radcliffe and Ristvedt discuss treatment of glaucoma with iDose TR
By rd360stg
Gene therapy demonstrates safety and efficacy in XLRP
By rd360stg
Dr. ElMallah presents 2-year results of study on IOP lowering with iDose TR
-Advertisement-
-Advertisement-
Videos
All
Dr. Christine Kay highlights the TEASE study for Stargardt disease
31 Oct, 2024

Christine Kay, MD, of Vitreo Retinal Associates in Gainesville, Florida,...

Modeling study observes extended durability of aflibercept 8 mg
30 Oct, 2024
Matching study assesses faricimab versus aflibercept in DME and AMD
30 Oct, 2024
-Advertisement-
-Advertisement-

Contact Info

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809

+908-505-8899
[email protected]

Social Links

© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved
-Advertisement-
-Advertisement-